Neoplasms Pancreatic: Clinical Trials

15 trials for Neoplasms Pancreatic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 terminated, 2 active not recruiting, 2 unknown. 8 Phase 2, 4 Not applicable, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 28Active not recruiting 2, Terminated 2, Withdrawn 2, Completed 1, Unknown 1
Not applicable4Completed 1, Recruiting 1, Terminated 1, Unknown 1
Phase 12Active not recruiting 1, Completed 1

Follow Neoplasms Pancreatic: new trials by email Literature Review of Neoplasms Pancreatic trials Research Report on Neoplasms Pancreatic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ImmunoPET Imaging of Pancreatic Cancer
[89Zr]Zr-DFO-SHR1920, [18F]F-RESCA-3A12, [68Ga]Ga-NOTA-3A12 - Neoplasms Pancreatic
Not applicableRecruitingRenJi Hospital902024-11-202025-12-29
A Trial of Gemcitabine, Pembrolizumab and IMM-101 as First Line Treatment in Patients With Metastatic Pancreatic Cancer
IMM-101, Pembrolizumab, Gemcitabine - Neoplasms Pancreatic
Phase 2WithdrawnKaren Carty2024-06-172025-07-11
Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer
avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel - KRAS Activating Mutation, Metastatic Cancer
Phase 1 / Phase 2Active not recruitingVerastem, Inc.402023-03-222025-09-02
Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies
ctDNA blood sampling - Neoplasm, Colorectal, Neoplasm of Lung
CompletedRoyal Marsden NHS Foundation Trust1282020-06-182025-04-06
A New Prognostic Score Model for Pancreatic Ductal Adenocarcinoma
pancreatic cancer surgery - Neoplasms Pancreatic
CompletedZhejiang University3022019-09-012022-09-22
Delay to Diagnosis in Digestive Cancerology by the General Practitioner Related to Covid-19 Pandemic Confinement
Neoplasms, Colorectal, General Practitioner
CompletedUniversity of Bordeaux3762019-06-012023-11-07
PRIMUS002: Looking at 2 Neo-adjuvant Treatment Regimens for Resectable and Borderline Resectable Pancreatic Cancer
FOLFOX-A, AG - Neoplasms Pancreatic
Phase 2TerminatedJudith Dixon-Hughes312019-03-052022-05-24
9-ING-41 in Patients With Advanced Cancers
9-ING-41, Gemcitabine - 21 day cycle, Doxorubicin. - Cancer, Pancreatic Cancer
Phase 2Active not recruitingActuate Therapeutics Inc.3502019-01-042026-04-03
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer
Nab-paclitaxel, Gemcitabine, Capecitabine - Adenocarcinoma, Pancreatic Neoplasms
Phase 1 / Phase 2CompletedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins482018-06-212024-12-31
Precision-Panc Master Protocol: Personalising Treatment for Pancreatic Cancer
Patients with suspected or confirmed pancreatic cancer will be be asked to provide biopsy material for molecular profiling - Neoplasms Pancreatic
Not applicableUnknownJudith Dixon-Hughes25002017-11-282024-02-08
PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer
FOLFOX-A, Gemcitabe and Abraxane, G-CSF - Neoplasms Pancreatic
Phase 2UnknownJudith Dixon-Hughes5002017-11-282024-02-08
The Effect of Cannabis in Pancreatic Cancer
THC and CBD Mixture - Neoplasms Pancreatic, Cachexia; Cancer
Phase 2WithdrawnJens Rikardt Andersen2017-10-062023-12-18
Percutaneous Immunostimulating Interstitial Laser Thermotherapy in Pancreatic Cancer
imILT, Standard chemotherapy treatment - Neoplasms Pancreatic
Not applicableTerminatedClinical Laserthermia Systems AB82017-05-172021-07-07
Immunostimulating Interstitial Laser Thermotherapy in Pancreatic Cancer
Immunostimulating Interstitial Laser Thermotherapy - Neoplasms Pancreatic
Not applicableCompletedClinical Laserthermia Systems AB52016-10-012020-12-17
Gemcitabine and CT-011 for Resected Pancreatic Cancer
CT-011, Gemcitabine - Pancreatic Neoplasms, Cancer of the Pancreas
Phase 2TerminatedAugusta University22012-09-012019-07-10

Narrower conditions

Pancreatic Neoplasms (15)  ·  Colorectal Neoplasms (3)  ·  Neoplasms (3)  ·  Hyperthermia (2)  ·  Lung Neoplasms (2)  ·  Neoplasm Metastasis (2)  ·  Adenocarcinoma (1)  ·  Anorexia (1)  ·  Biliary Tract Neoplasms (1)  ·  Bone Neoplasms (1)  ·  Breast Neoplasms (1)  ·  COVID-19 (1)  ·  Cachexia (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)

Broader conditions

Neoplasms by Site (15)  ·  Digestive System Diseases (14)  ·  Digestive System Neoplasms (14)  ·  Endocrine Gland Neoplasms (14)  ·  Endocrine System Diseases (14)  ·  Pancreatic Diseases (14)  ·  Neoplasms (12)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Gastrointestinal Diseases (4)  ·  Colonic Diseases (3)  ·  Gastrointestinal Neoplasms (3)  ·  Intestinal Diseases (3)  ·  Intestinal Neoplasms (3)  ·  Lung Diseases (3)  ·  Pathologic Processes (3)

Interventions

Gemcitabine (5)  ·  Albumin-Bound Paclitaxel (4)  ·  130-nm albumin-bound paclitaxel (2)  ·  Irinotecan (2)  ·  3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione (1)  ·  Capecitabine (1)  ·  Carboplatin (1)  ·  Cisplatin (1)  ·  Doxorubicin (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  IMM-101 (1)  ·  Lomustine (1)  ·  Paclitaxel (1)  ·  Taxes (1)  ·  defactinib (1)

Sponsors

Judith Dixon-Hughes (3)  ·  Clinical Laserthermia Systems AB (2)  ·  Actuate Therapeutics Inc. (1)  ·  Augusta University (1)  ·  Jens Rikardt Andersen (1)  ·  Karen Carty (1)  ·  RenJi Hospital (1)  ·  Royal Marsden NHS Foundation Trust (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)  ·  University of Bordeaux (1)  ·  Verastem, Inc. (1)  ·  Zhejiang University (1)

Countries

United Kingdom (5)  ·  United States (4)  ·  France (3)  ·  China (2)  ·  Portugal (2)  ·  Belgium (1)  ·  Canada (1)  ·  Denmark (1)  ·  Netherlands (1)  ·  Spain (1)

Top investigators

David Chang (2)  ·  Belarmino Goncalves, MD (1)  ·  Derek Grose (1)  ·  Dung Le, MD (1)  ·  Janet Graham (1)  ·  Jeff Evans (1)  ·  Jens Rikardt Andersen, MD, MPA (1)  ·  Jianjun Liu, PhD (1)  ·  Juan Valle (1)  ·  Justin Mencel, MBBS (1)  ·  MD Verastem (1)  ·  Samir N. Khleif, MD (1)  ·  Tingbo Liang (1)  ·  Weijun Wei, Ph.D. & M.D. (1)

Results publications

PMID 37378896, PMID 12648025, PMID 16317825, PMID 17566383, PMID 18728826, PMID 19587829, PMID 19883531, PMID 19896326, PMID 20076976, PMID 22076835, PMID 23141881, PMID 24327518, PMID 26883879, PMID 27403414, PMID 27424289, PMID 28053024, PMID 28672195, PMID 29383130, PMID 29846250, PMID 30405781, PMID 30975030, PMID 31101621, PMID 31401903, PMID 31533931, PMID 31831767, PMID 31882719, PMID 31894292, PMID 33278792, PMID 35815408, PMID 41981308, PMID 42095609